Author Archives: Julian Upton

Orphan Drug Market to Reach $176 Billion by 2020, Says Report

By 2020, orphan drugs are expected to account for 19 percent of the total share of prescription drug sales excluding generics, reaching $176 billion in annual sales, according to EvaluatePharma’s Orphan Drug Report 2014. At 11 percent, this growth is set to be more than double the 5 percent growth rate of the overall prescription market, […]
Posted in Global, Orphan Drugs | Tagged , , , | Leave a comment

Alfred Hitchcock — Pharma Rep

In 1955, the broadcaster CBS proposed a deal with drugmaker Bristol-Myers (as it was then known) to sponsor a new TV show, Alfred Hitchcock Presents. The show, scheduled to premier later that year, would be a weekly anthology series focused on crime and mystery stories. The unique selling point was that Hitchcock himself was to […]
Posted in Marketing | Tagged , , , , , | Leave a comment

Emerging Pharma Leaders: Ian Harris, Janssen Research & Development

When he left school, Ian Harris wanted a career in brewing. He enrolled on a biochemistry degree with the intention of going on to study a master’s in brewing at Heriot-Watt University in Edinburgh, UK. But after spending, as part of his first degree, a year in the pharmacutical industry developing in vitro disease models for dermatology […]
Posted in leadership, People | Tagged | Leave a comment

EMA Invites Comments on Good Biomarker Practice

The European Medicines Agency (EMA) has released a consultation on good genomics biomarker practices. The outcome of the consultation will inform a guideline, which will set criteria to underpin the generation of robust clinical genomic datasets throughout a medicine’s lifecycle,  the choice of genomic techniques and biomarkers, the impact on the relevant study design, and the […]
Posted in Biotech, Europe, Global, Regulatory | Tagged , , | Leave a comment

UK Strengthens Drive to Tackle Dementia

The UK government pledged late last year that it would double funding for dementia research by 2025 (from £66m [US$112m] in 2015 to £122m [US$207m]), but today Prime Minister David Cameron spoke on the subject again in light of expert warnings that little progress is being made. At the first legacy event of the G8 […]
Posted in Europe, Events, Gene therapy, Global, healthcare | Tagged , , , | Leave a comment
  • Categories

  • Meta